Additionally, DYRK1A has been found to be a promoter of fibroblast-like synoviocytes (FLS), which play a role in cartilage/bone destruction in rheumatoid arthritis (RA) via activation of the ERK/MAPK pathway (Guo et al., 2018). Here, DYRK1A is linked to rheumatoid arthritis.